Cargando…

Assembly of HCV E1 and E2 glycoproteins into coronavirus VLPs

Hepatitis C virus (HCV) is believed to assemble by budding into membranes of the early secretory pathway, consistent with the membrane location where the viral envelope glycoproteins E1 and E2 accumulate when expressed. Coronavirus assembly also takes place at pre-Golgi membranes. Here, we generated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jourdan, N., Godeke, G.-J., Penaud, M., Mottola, G., Sorrentino, A., Rottier, P. J. M., Bonatti, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2006
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087226/ https://www.ncbi.nlm.nih.gov/pubmed/16648962 http://dx.doi.org/10.1007/s00705-006-0769-0

Ejemplares similares

Down-regulation of CD81 in human cells producing HCV-E1/E2 retroVLPs
por: Rodrigues, Ana F, et al.
Publicado: (2011)

Identification of porcine alveolar macrophage glycoproteins involved in infection of porcine respiratory and reproductive syndrome virus
por: Wissink, E. H. J., et al.
Publicado: (2003)

Signal recognition particle-dependent insertion of coronavirus E1, an intracellular membrane glycoprotein.
por: Rottier, P, et al.
Publicado: (1985)

Functional RNAs: combined assembly and packaging in VLPs
por: Fang, Po-Yu, et al.
Publicado: (2017)

Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes.
por: Vennema, H, et al.
Publicado: (1996)

Sequence and topology of a model intracellular membrane protein, E1 glycoprotein, from a coronavirus
por: Armstrong, John, et al.
Publicado: (1984)

Optimized Hepatitis C Virus (HCV) E2 Glycoproteins and their Immunogenicity in Combination with MVA-HCV
por: Marín, María Q., et al.
Publicado: (2020)

RNA: packaged and protected by VLPs
por: Fang, Po-Yu, et al.
Publicado: (2018)

Coronavirus glycoprotein E1, a new type of viral glycoprotein()
por: Niemann, H., et al.
Publicado: (1981)

Improving the aqueous solubility of HCV‐E2 glycoprotein epitope mimics by cyclization using POLAR hinges
por: Meuleman, Theodorus J., et al.
Publicado: (2020)

Design and Synthesis of HCV-E2 Glycoprotein Epitope Mimics in Molecular Construction of Potential Synthetic Vaccines
por: Meuleman, Theodorus J., et al.
Publicado: (2021)

Molecular Interactions in the Assembly of Coronaviruses
por: de Haan, Cornelis A.M., et al.
Publicado: (2005)

Packaging of actin into Ebola virus VLPs
por: Han, Ziying, et al.
Publicado: (2005)

114 VLPs and particle vaccines
por: Buonaguro, Luigi
Publicado: (2014)

Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2
por: El Abd, Yasmine S, et al.
Publicado: (2011)

Identification of a Novel Drug Lead That Inhibits HCV Infection and Cell-to-Cell Transmission by Targeting the HCV E2 Glycoprotein
por: Al Olaby, Reem R., et al.
Publicado: (2014)

Envelope glycoprotein interactions in coronavirus assembly
Publicado: (1995)

Coronavirus envelope (E) protein remains at the site of assembly
por: Venkatagopalan, Pavithra, et al.
Publicado: (2015)

Antigenic structure of the E2 glycoprotein from transmissible gastroenteritis coronavirus
por: Correa, Isabel, et al.
Publicado: (1988)

Identification of Aptamer-Binding Sites in Hepatitis C Virus Envelope Glycoprotein E2
por: Chen, Fan, et al.
Publicado: (2015)

Membrane integration and intracellular transport of the coronavirus glycoprotein E1, a class III membrane glycoprotein.
por: Mayer, T, et al.
Publicado: (1988)

The Coronavirus E Protein: Assembly and Beyond
por: Ruch, Travis R., et al.
Publicado: (2012)

Post-translational glycosylation of coronavirus glycoprotein E1: inhibition by monensin.
por: Niemann, H, et al.
Publicado: (1982)

Nucleotide sequence of the gene encoding the membrane protein of human coronavirus 229 E
por: Raabe, T., et al.
Publicado: (1989)

An ultralong CDRH2 in HCV neutralizing antibody demonstrates structural plasticity of antibodies against E2 glycoprotein
por: Flyak, Andrew I, et al.
Publicado: (2020)

Hepatitis C Virus (HCV) Envelope Glycoproteins E1 and E2 Contain Reduced Cysteine Residues Essential for Virus Entry
por: Fraser, Johanna, et al.
Publicado: (2011)

Identifying immunologically-vulnerable regions of the HCV E2 glycoprotein and broadly neutralizing antibodies that target them
por: Quadeer, Ahmed A., et al.
Publicado: (2019)

Structure-Based Design of Porcine Circovirus Type 2 Chimeric VLPs (cVLPs) Displays Foreign Peptides on the Capsid Surface
por: Wang, Dongliang, et al.
Publicado: (2018)

High-Throughput Sequencing Analysis of Post-Liver Transplantation HCV E2 Glycoprotein Evolution in the Presence and Absence of Neutralizing Monoclonal Antibody
por: Babcock, Gregory J., et al.
Publicado: (2014)

Construction of HER2-Specific HIV-1-Based VLPs
por: Martins, Sofia A., et al.
Publicado: (2022)

Abrogation of contaminating RNA activity in HIV-1 Gag VLPs
por: Valley-Omar, Ziyaad, et al.
Publicado: (2011)

Antigenic variation among murine coronaviruses: Evidence for polymorphism on the peplomer glycoprotein, E2
por: Talbot, Pierre J., et al.
Publicado: (1985)

Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs against Human Coronavirus 229E (HCoV-229E)
por: Parang, Keykavous, et al.
Publicado: (2020)

Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer
por: Walls, Alexandra C., et al.
Publicado: (2016)

Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs
por: Zepeda-Cervantes, Jesús, et al.
Publicado: (2020)

Circulation of human coronaviruses OC43 and 229E in Córdoba, Argentina
por: Ottogalli, María Emilia, et al.
Publicado: (2021)

Monoclonal antibodies to bovine coronavirus: Characteristics and topographical mapping of neutralizing epitopes on the E2 and E3 glycoproteins()
por: Deregt, Dirk, et al.
Publicado: (1987)

Production of the HBc Protein from Different HBV Genotypes in E. coli. Use of Reassociated HBc VLPs for Packaging of ss- and dsRNA
por: Petrovskis, Ivars, et al.
Publicado: (2021)

Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein
por: Sautto, Giuseppe A, et al.
Publicado: (2016)

Association of the Sialylation of Antibodies Specific to the HCV E2 Envelope Glycoprotein with Hepatic Fibrosis Progression and Antiviral Therapy Efficacy
por: Kurtenkov, Oleg, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tu3qjk4jbdai9lht6vsscnc6g6